BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10578010)

  • 21. VEGF gene delivery for treatment of ischemic cardiovascular disease.
    Koransky ML; Robbins RC; Blau HM
    Trends Cardiovasc Med; 2002 Apr; 12(3):108-14. PubMed ID: 12007735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization.
    Sayeed-Shah U; Mann MJ; Martin J; Grachev S; Reimold S; Laurence R; Dzau V; Cohn LH
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):763-9. PubMed ID: 9806383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic angiogenesis for ischemic cardiovascular disease.
    Freedman SB; Isner JM
    J Mol Cell Cardiol; 2001 Mar; 33(3):379-93. PubMed ID: 11181008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenesis for revascularization of ischaemic tissues.
    Isner JM
    Eur Heart J; 1997 Jan; 18(1):1-2. PubMed ID: 9049503
    [No Abstract]   [Full Text] [Related]  

  • 25. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.
    Su H; Lu R; Kan YW
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13801-6. PubMed ID: 11095751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium.
    Tio RA; Tkebuchava T; Scheuermann TH; Lebherz C; Magner M; Kearny M; Esakof DD; Isner JM; Symes JF
    Hum Gene Ther; 1999 Dec; 10(18):2953-60. PubMed ID: 10609656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.
    Lee M; Rentz J; Bikram M; Han S; Bull DA; Kim SW
    Gene Ther; 2003 Sep; 10(18):1535-42. PubMed ID: 12907944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmyocardial laser revascularization combined with vascular endothelial growth factor 121 (VEGF121) gene therapy for chronic myocardial ischemia--do the effects really add up?
    Heilmann CA; Attmann T; von Samson P; Göbel H; Marmé D; Beyersdorf F; Lutter G
    Eur J Cardiothorac Surg; 2003 Jan; 23(1):74-80. PubMed ID: 12493508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.
    Carmeliet P; Ng YS; Nuyens D; Theilmeier G; Brusselmans K; Cornelissen I; Ehler E; Kakkar VV; Stalmans I; Mattot V; Perriard JC; Dewerchin M; Flameng W; Nagy A; Lupu F; Moons L; Collen D; D'Amore PA; Shima DT
    Nat Med; 1999 May; 5(5):495-502. PubMed ID: 10229225
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review.
    Kusumanto YH; Hospers GA; Mulder NH; Tio RA
    Int J Cardiovasc Intervent; 2003; 5(1):27-34. PubMed ID: 12623562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenesis, protein and gene delivery.
    Azrin M
    Br Med Bull; 2001; 59():211-25. PubMed ID: 11756212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramuscular vascular endothelial growth factor gene therapy: fact or fiction?
    Baumgartner I
    Am J Med; 2003 Feb; 114(2):156-7. PubMed ID: 12586239
    [No Abstract]   [Full Text] [Related]  

  • 33. Vascular growth factors for coronary angiogenesis.
    Lee CH; Smits PC
    J Interv Cardiol; 2002 Dec; 15(6):511-8. PubMed ID: 12476656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenic gene therapy. A leg to stand on?
    Fox JC; Swain JL
    Circulation; 1996 Dec; 94(12):3065-6. PubMed ID: 8989107
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gene therapy for peripheral arterial diseases in diabetes mellitus].
    Makino H; Ogihara T; Morishita R
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():449-56. PubMed ID: 12430268
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic angiogenesis in ischemic limbs.
    Folkman J
    Circulation; 1998 Mar; 97(12):1108-10. PubMed ID: 9537334
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination TMR and gene therapy.
    Sayeed-Shah U; Reul RM; Byrne JG; Aranki SF; Cohn LH
    Semin Thorac Cardiovasc Surg; 1999 Jan; 11(1):36-9. PubMed ID: 9930710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor.
    Sueishi K; Yonemitsu Y; Nakagawa K; Kaneda Y; Kumamoto M; Nakashima Y
    Ann N Y Acad Sci; 1997 Apr; 811():311-22; 322-4. PubMed ID: 9186607
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neovasculation in ischemic heart disease].
    Minamino T; Komuro I
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():154-60. PubMed ID: 12734969
    [No Abstract]   [Full Text] [Related]  

  • 40. Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial ischemia.
    Xu X; Li J; Simons M; Li J; Laham RJ; Sellke FW
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):735-42. PubMed ID: 11279416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.